Skip to main content

The 7 Best Fidelity Mutual Funds to Buy and Hold

Financial advisors generally discourage investors from choosing mutual funds based solely on past performance. This goes beyond the common warning that past results do not predict future returns.

It also reflects concerns about recency bias, where investors chase mutual funds that have recently done well without understanding the risks involved. Performance figures on their own can be misleading because they do not show how much volatility or downside risk a fund took to achieve those returns.

[Sign up for stock news with our Invested newsletter.]

A fund’s annualized total return, typically shown over one-, three-, five- or 10-year periods, does not capture the path taken to get there. Two funds may post similar long-term returns, but one could have experienced far larger swings along the way.

For example, a sector fund focused on semiconductors may deliver strong long-term gains but also go through sharp drawdowns. If those swings exceed an investor’s tolerance, they may panic sell at the wrong time, undermining the benefit of those returns.

To address this, investors and fund managers often look at risk-adjusted metrics. Standard deviation measures how much a fund’s returns have varied over time, while the Sharpe ratio evaluates how much excess return a fund generated per unit of risk. These tools provide more context, but they can still be difficult to interpret without experience.

That is where third-party systems like the Morningstar star rating come in. This methodology compares a fund’s risk-adjusted performance to peers in its category over three-, five- and 10-year periods.

Funds are rated from one to five stars, with five-star funds representing the top 10% of their peer group. Ratings are updated monthly and require at least three years of performance data, with some funds also receiving an overall rating based on a weighted average of available periods.

Many fund providers highlight these ratings as a quick reference for investors. Fidelity Investments, for example, offers screening tools that allow investors to filter funds based on Morningstar ratings, which can then be ordered based on other important metrics like expense ratios.

Here are seven of the best Fidelity mutual funds to buy and hold, all of which currently carry an overall five-star Morningstar rating:

Fund Expense Ratio
Fidelity Multi-Asset Index Fund (ticker: FFNOX) 0.11%
Fidelity Balanced Fund (FBALX) 0.46%
Fidelity Puritan Fund (FPURX) 0.47%
Fidelity Freedom 2040 Fund (FFFFX) 0.66%
Fidelity Mega Cap Stock Fund (FGRTX) 0.58%
Fidelity Blue Chip Growth Fund (FBGRX) 0.61%
Fidelity Growth Discovery Fund (FDSVX) 0.62%

Fidelity Multi-Asset Index Fund (FFNOX)

“While it truly depends on each individual investor’s specific goals and objectives, I typically advocate for index funds in the accumulation phase, as these give great broad-market exposure with lower fees than actively managed funds,” says Wes Moss, managing partner and chief investment strategist at Capital Investment Advisors. FFNOX is a highly diversified index fund that can serve as a core holding.

FFNOX allocates across U.S. and international stocks and bonds. The portfolio is currently tilted toward equities, with only 15% allocated to bonds. All of the underlying holdings are index-based funds, helping keep costs low with a 0.11% expense ratio. Like most Fidelity funds, it has no minimum investment or transaction fees. FFNOX has delivered a 10.4% annualized return over the past 10 years.

Fidelity Balanced Fund (FBALX)

Some investors may find FFNOX’s allocation too aggressive, especially those nearing retirement. In that stage, preserving capital and generating income often take priority over capital appreciation. A more conservative alternative is FBALX, which allocates about 37% of its portfolio to bonds. This higher fixed-income exposure can help reduce volatility while also providing income, with a 1.8% 30-day SEC yield.

On the equity side, FBALX is tilted toward U.S. stocks, which make up about 59% of the portfolio, while international equities account for just 4%. Its bond holdings are primarily in U.S. Treasurys, along with some exposure to mortgage-backed securities and investment-grade corporate bonds. The fund charges a 0.46% expense ratio and has delivered a 10.9% annualized return over the past 10 years.

Fidelity Puritan Fund (FPURX)

FPURX follows a classic balanced approach of about 60% in equities and 40% in bonds. On the equity side, the fund focuses on growth-oriented companies that management believes are incorrectly priced relative to their long-term potential. For fixed income, it emphasizes investment-grade bonds while also adjusting exposure across sectors and yield curves, with a modest allocation to high-yield bonds for added return.

FPURX has flexibility to tilt that mix based on valuations and market conditions. That active approach has translated into strong results. Over the past 10 years, FPURX has delivered a 10.6% annualized return, outperforming the Morningstar “moderate allocation” peer category average of 8.1%. The fund has a long track record dating back to 1947 and remains reasonably priced, with a 0.47% expense ratio.

Fidelity Freedom 2040 Fund (FFFFX)

The previous Fidelity funds all use a set asset allocation between stocks and bonds, with some rebalancing periodically and others allowing managers to adjust the mix based on market conditions. Another approach is a target-date fund, which automatically shifts its allocation over time. A good example is FFFFX, designed for investors planning to retire around 2040.

As of 2026, the fund holds about 19% in bonds, which aligns with a longer time horizon of roughly 14 years to retirement. As the 2040 target date approaches, FFFFX will gradually reduce its equity exposure and increase its allocation to bonds. The goal is to move from growth toward capital preservation without requiring investors to actively manage the transition themselves.

[8 Top-Performing Fidelity Funds for Retirement]

Fidelity Mega Cap Stock Fund (FGRTX)

Investors with a higher risk tolerance who want to prioritize capital appreciation may find balanced allocation funds too conservative. FGRTX offers an equity-focused approach by investing in mega-cap companies found in benchmarks like the Russell Top 200 Index or the S&P 100. The fund is style-agnostic between growth and value, falling into the large-blend style box category.

FGRTX’s sector weights differ meaningfully from the S&P 500. Technology accounts for 26.4% of the fund versus 32.9% in the index, while it places greater emphasis on energy, with a 10.6% allocation compared to 4% in the S&P 500. Over the past 10 years, FGRTX has delivered a 15.5% annualized return, outperforming both the S&P 500 index and the Morningstar “large-blend” peer category.

Fidelity Blue Chip Growth Fund (FBGRX)

Investors who want to keep a large-cap focus but lean more toward growth may prefer FBGRX. The fund targets “well-known, well-established and well-capitalized” companies, often referred to as blue chips, under manager Sonu Kalra, who has led the fund since 2009. Over the past 10 years, FBGRX has delivered a 19.2% annualized return, outperforming the Russell 1000 Growth Index, at 16.8%.

FBGRX’s portfolio is more concentrated than a typical S&P 500 index fund. The top 10 holdings make up 61.1% of assets, and the fund carries a significant tilt toward technology, at about 49% of the portfolio. FBGRX charges a 0.61% expense ratio. Investors can also access this strategy in ETF format via the Fidelity Blue Chip Growth ETF (FBCG) at a lower 0.57% expense ratio.

Fidelity Growth Discovery Fund (FDSVX)

FBGRX is not the only strong-performing Fidelity growth fund. FDSVX offers a similar large-cap growth bias but with less emphasis on traditional blue-chip names. The fund focuses on companies with above-average earnings growth, positive earnings revisions, strong profit margins and durable long-term earnings power. It charges a 0.62% expense ratio, making it marginally pricier than FBGRX.

Over the past 10 years, FDSVX has delivered a 17.1% annualized return, outperforming its benchmark, the Russell 3000 Growth Index, which returned 16.4%. The portfolio is still relatively concentrated, with the top 10 holdings accounting for 54.2% of assets and a 43.7% allocation to the technology sector. Notably, semiconductor stocks play a key role, with Nvidia Corp. (NVDA) as the top holding, at 13.5%.

More from U.S. News

7 Best Vanguard Funds to Buy and Hold

7 Best Funds for Retirement

7 of the Best 5-Star ETFs to Buy

The 7 Best Fidelity Mutual Funds to Buy and Hold originally appeared on usnews.com

Update 04/29/26: This story was previously published at an earlier date and has been updated with new information.

Judge rebukes Trump and DOJ over IRS lawsuit in scathing decision

▶ Watch Video: Rep. Jamie Raskin on "anti-weaponization" fund: "We need to stop it" Washington — A federal judge on Monday imposed professional penalties against lawyers representing President Trump in a civil lawsuit he brought against the IRS and harshly criticized the Justice Department for its handling of the case, concluding that the suit was brought for an "improper purpose."In a scathing 56-page decision, U.S. District Judge Kathleen Williams referred one of Mr. Trump's lawyers, Alejandro Brito, to the Florida Bar for potential disciplinary action. The judge limited the ability of a second lawyer, Daniel Epstein, to practice in the Southern District of Florida.Williams also barred the Justice Department, IRS and Mr. Trump from citing or using provisions of a deal the two sides reached in judicial, administrative, regulatory or other proceedings as evidence of a settlement in the case.The case, Williams wrote, "was brought for an improper purpose — to gain the imprimatur of judicial legitimacy for a 'settlement' that had no viable basis in law or fact." Additionally, the president and his two older sons, who were plaintiffs alongside Mr. Trump, "acted in bad faith," she concluded."In sum, the facts before this Court demonstrate there was never adverseness between the Parties; there was never a case or controversy; and there was never a question as to who would prevail," she said.Williams also directed a copy of her order to be mailed to the State Bar of New York and to the District of Columbia Bar, of which acting Attorney General Todd Blanche and Associate Attorney General Stanley Woodward are members, respectively. Blanche and Woodward signed documents relating to the settlement with Mr. Trump.Brito and Epstein did not immediately respond to a request for comment.Williams' extraordinary order came in response to concerns raised by a group of 35 former judges about the settlement agreement reached in May. The deal brought to an end the $10 billion civil lawsuit the president and his two oldest sons filed against the IRS earlier this year over the leak of Mr. Trump's tax returns by a government contractor.The settlement initially included the creation of a $1.776 billion "anti-weaponization" fund that aimed to provide taxpayer-funded payouts to individuals who alleged the federal government had been "weaponized" against them. But after immense blowback from Congress and a federal judge's ruling, Blanche said the Justice Department was "not moving forward" with the program.Another provision of the settlement that permanently bars the IRS from pursuing tax claims against Mr. Trump, his oldest sons, his company or affiliated companies of his family remains intact.The former judges asked Williams in May to reopen the case between Mr. Trump and his administration, arguing that the agreement they reached to resolve the president's civil lawsuit was "the product of collusion" and a "fraud on the court." The settlement was reached as Williams was weighing whether she even had jurisdiction over the case. In her order, Williams said that there was no case or controversy for the court to decide. Since it was filed by Mr. Trump against a federal agency and officials that he, as president, had control over, there would be no adverse litigant, she found. Williams determined that Mr. Trump "improperly employed this lawsuit to justify a particular award in this matter — access to taxpayer funds and exemption from audits and other investigations — which was accomplished by leveraging control over Defendants.""President Trump did not pursue his claims until he once again occupied the White House and had appointed his former lawyer, and the former lawyer of persons who are putative beneficiaries of the 'Anti-Weaponization Fund' to prominent positions in the DOJ," she wrote in her order. "These officials then negotiated on behalf of the United States, with his current lawyers, including his former White House Counsel to reach a 'settlement.' It is risible to suggest that there was ever adverseness between the Parties."Williams excoriated the Justice Department for its handling of the case and accused it of "abdicating its responsibility to zealously defend the interests of the United States." By entering into the settlement with Mr. Trump, Williams said the administration "disregarded DOJ policies, and accomplished objectives beyond those authorized, as well as those specifically prohibited, by law.""The nature of the suit itself and the conduct of the Parties and counsel from its filing make plain that this was an attempt to use the Court to provide some legitimacy to an agreement to confer immunity to people and entities affiliated with the President and to earmark billions of dollars from American taxpayers to redress grievances not defined in the law," Williams wrote. "The President may be the functional 'dominus litus' of the Executive Branch, but as a party to a civil suit, he, as well as all the parties and lawyers before a court, are bound by the rules."The judge, who was appointed by President Barack Obama, rejected characterizations of the case as "ordinary" by Mr. Trump and his lawyers, calling it a "startling misstatement.""Lead Plaintiff and Defendants are public servants — the pinnacle of the Executive Branch — sworn to uphold the law, faithfully perform the duties of their office, and protect the interests of the American public," she wrote. "The issue before the Court is whether, instead, they ignored ethical norms, court rules, and legal authority to manipulate the judicial process. The issue is whether they did so to gild their efforts to gain unprecedented access to the public fisc with the patina of legitimacy. There is nothing 'ordinary' about this case."Williams also took aim at the government lawyers working the case, saying the Trump administration "failed to defend this lawsuit or to respond to the Court's jurisdictional inquiry because its position would not withstand judicial scrutiny."She said the $1.776 billion pledged for the "anti-weaponization" fund "speaks of a 'branding' effort rather than a deliberate and thoughtful calculation of damages."The judge's order comes days before Blanche is set to appear before the Senate Judiciary Committee for his confirmation hearing for attorney general. He is expected to face sharp questions regarding the creation of the "anti-weaponization" fund and the effective grant of immunity to Mr. Trump. The president formally nominated Blanche, who served as Mr. Trump's private criminal defense attorney, to lead the Justice Department last month.
Read Next Story